Molecular profiling of platinum resistant ovarian cancer-Reference-Cited by-同舟云学术

Molecular profiling of platinum resistant ovarian cancer

Published:2005-11-14 Issue:8 Volume:118 Page:1963-1971
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Helleman Jozien,Jansen Maurice P.H.M.,Span Paul N.,van Staveren Iris L.,Massuger Leon F.A.G.,Meijer-van Gelder Marion E.,Sweep Fred C.G.J.,Ewing Patricia C.,van der Burg Maria E.L.,Stoter Gerrit,Nooter Kees,Berns Els M.J.J.

Funder

Erasmus MC Revolving Fund

Dutch Cancer Society, Amsterdam, the Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference54 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Gene expression patterns in ovarian carcinomas;Schaner;Mol Biol Cell,2003

3. Cancer burden in the year 2000. The global picture;Parkin;Eur J Cancer,2001

4. Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis;Harries;Lancet Oncol,2002

5. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer;van der Burg;N Engl J Med,1995

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the structure–function relationship of missense mutations in the human TOP2A protein in ovarian cancer;Frontiers in Physics;2024-03-28

2. The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC);Human Genetics;2024-01-26

3. Discovery and preliminary validation of a new panel of personalized ovarian cancer biomarkers for individualized detection of recurrence;F1000Research;2023-11-23

4. Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas;International Journal of Molecular Sciences;2023-08-25

5. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer;Frontiers in Genetics;2022-08-12